Related content

Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy

By Mariani Luciano   Gadducci Angiolo   Vizza Enrico   Tomao Silverio   Vici Patrizia  

Gynecological Endocrinology, Vol. 29, Iss. 1, 2013-01 ,pp. : 25-29

Informa Healthcare

Access to resources Recommend Favorite

Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study

By Biglia Nicoletta   Peano Elisa   Sgandurra Paola   Moggio Giulia   Panuccio Enrico   Migliardi Marco   Ravarino Nicoletta   Ponzone Riccardo   Sismondi Piero  

Gynecological Endocrinology, Vol. 26, Iss. 6, 2010-06 ,pp. : 404-412

Informa Healthcare

Access to resources Recommend Favorite

Postmenopausal vaginal atrophy correlates with decreased estradiol and body mass index and does not depend on the time since menopause

By Repse-fokter Alenka   Takac Iztok   Fokter Samo  

Gynecological Endocrinology, Vol. 24, Iss. 7, 2008-01 ,pp. : 399-404

Informa Healthcare

Access to resources Recommend Favorite

High local endometrial effect of vaginal progesterone gel

By Ficicioglu C   Gurbuz B   Tasdemir S   Yalti S   Canova H  

Gynecological Endocrinology, Vol. 18, Iss. 5, 2004-05 ,pp. : 240-243

Informa Healthcare

Access to resources Recommend Favorite

Vaginal pH-lowering effect of locally applied vitamin C in subjects with high vaginal pH

By Polatti Franco   Rampino Mariangela   Magnani Paola   Mascarucci Paolo  

Gynecological Endocrinology, Vol. 22, Iss. 4, 2006-04 ,pp. : 230-234

Informa Healthcare

Access to resources Recommend Favorite